Literature DB >> 11166825

Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia.

T Inaba1, C Shimazaki, T Sumikuma, N Ochiai, A Okano, M Hatsuse, E Ashihara, Y Kobayashi, K Rin, S Murakami, H Haruyama, N Fujita, M Nakagawa.   

Abstract

Four patients (three males and one female) were diagnosed as myeloid/natural killer (NK) cell precursor acute leukemia in our department. Two patients showed the extramedullary involvement at initial presentation. Leukemic cells expressed CD7, CD33, CD45 and CD56 in all patients. Additionally, CD13, CD34, HLA-DR, cytoplasmic CD3 and myeloperoxidase were expressed in some patients. Trisomy 10 was found in two patients, which has not been reported in this disease. Therefore, myeloid/NK cell precursor acute leukemia might be rather heterogeneous especially in chromosomal abnormality though it seemed to constitute the distinct clinical entity among acute myeloid leukemia of M0 subtype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166825     DOI: 10.1016/s0145-2126(00)00099-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

Authors:  Ritsuro Suzuki; Makoto Murata; Masahiro Kami; Shigeki Ohtake; Norio Asou; Yoshihisa Kodera; Masao Tomonaga; Yasufumi Masaki; Shuya Kusumoto; Jin Takeuchi; Shin Matsuda; Hisamaru Hirai; m Seiichi Yorimitsu; Nobuyuki Hamajima; Masao Seto; Masanori Shimoyama; Ryuzo Ohno; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

2.  Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.

Authors:  Kayo Tezuka; Hideki Nakayama; Keiko Honda; Junji Suzumiya; Kouichi Oshima; Toshiyuki Kitoh; Eiichi Ishii
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.319

3.  Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Curr Treat Options Oncol       Date:  2003-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.